Publications

ZORA Publication List

Publications

• 2014

  • Journal Article

    • Maiolica, A., de Medina-Redondo, M., Schoof, E. M., Chaikuad, A., Villa, F., Gatti, M., et al, & Penengo, L. (2014). Modulation of the chromatin phosphoproteome by the Haspin protein kinase Molecular & Cellular Proteomics, 13, 1724–1740. https://doi.org/10.1074/mcp.M113.034819

• 2012

  • Journal Article

    • Gatti, M., Pinato, S., Maspero, E., Soffientini, P., Polo, S., & Penengo, L. (2012). A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by RNF168 ubiquitin ligase Cell Cycle, 11, 2538–2544. https://doi.org/10.4161/cc.20919

• 2011

  • Journal Article

    • Pinato, S., Gatti, M., Scandiuzzi, C., Confalonieri, S., & Penengo, L. (2011). UMI, a novel RNF168 ubiquitin binding domain involved in the DNA damage signaling pathway Molecular and Cellular Biology, 31, 118–126. https://doi.org/10.1128/MCB.00818-10

• 2009

  • Journal Article

    • Pinato, S., Scandiuzzi, C., Arnaudo, N., Citterio, E., Gaudino, G., & Penengo, L. (2009). RNF168, a new RING finger, MIU-containing protein that modifies chromatin by ubiquitination of histones H2A and H2AX BMC Molecular Biology, 10, 55. https://doi.org/10.1186/1471-2199-10-55

• 2007

  • Journal Article

    • Woelk, T., Sigismund, S., Penengo, L., & Polo, S. (2007). The ubiquitination code: a signalling problem Cell Division, 2, 11. https://doi.org/10.1186/1747-1028-2-11

• 2006

  • Journal Article

    • Germano, S., Barberis, D., Santoro, M. M., Penengo, L., Citri, A., Yarden, Y., & Gaudino, G. (2006). Geldanamycins trigger a novel Ron degradative pathway, hampering oncogenic signaling Journal of Biological Chemistry, 281, 21710–21719. https://doi.org/10.1074/jbc.M602014200
    • Penengo, L., Mapelli, M., Murachelli, A. G., Confalonieri, S., Magri, L., Musacchio, A., Di Fiore, P. P., Polo, S., & Schneider, T. R. (2006). Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin Cell, 124, 1183–1195. https://doi.org/10.1016/j.cell.2006.02.020

• 2003

  • Journal Article

    • Penengo, L., Rubin, C., Yarden, Y., & Gaudino, G. (2003). c-Cbl is a critical modulator of the Ron tyrosine kinase receptor Oncogene, 22, 3669–3679. https://doi.org/10.1038/sj.onc.1206585

• 2001

  • Journal Article

    • Cacciotti, P., Libener, R., Betta, P., Martini, F., Porta, C., Procopio, A., Strizzi, L., Penengo, L., Tognon, M., Mutti, L., & Gaudino, G. (2001). SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma Proceedings of the National Academy of Sciences of the United States of America, 98, 12032–12037. https://doi.org/10.1073/pnas.211026798
    • Brunelleschi, S., Penengo, L., Lavagno, L., Santoro, C., Colangelo, D., Viano, I., & Gaudino, G. (2001). Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin British Journal of Pharmacology, 134, 1285–1295. https://doi.org/10.1038/sj.bjp.0704356

• 2000

  • Journal Article

    • Santoro, M. M., Penengo, L., Orecchia, S., Cilli, M., & Gaudino, G. (2000). The Ron oncogenic activity induced by the MEN2B-like substitution overcomes the requirement for the multifunctional docking site Oncogene, 19, 5208–5211. https://doi.org/10.1038/sj.onc.1203819

• 1998

  • Journal Article

    • Santoro, M. M., Penengo, L., Minetto, M., Orecchia, S., Cilli, M., & Gaudino, G. (1998). Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor Oncogene, 17, 741–749. https://doi.org/10.1038/sj.onc.1201994

Pagination